Pharmacogenetics has evolved over the past few years into pharmacogenomics, shifting focus from individual candidate genes to genome-wide association studies. The latest installment in our Genomic Medicine series, Genomics and Drug Response, reviews recent pharmacogenetic and pharmacogenomic advances, and discusses how such advances are reflected in drug labels. The authors aim to provide assurance that advances resulting from the application of genomic science to drug therapy may assist with drug selection and dosing, and reduce the odds of adverse drug reactions. Earlier articles in this series include Genomics and the Continuum of Cancer Care — NEJM, Genomics, Type 2 Diabetes, and Obesity, Ancestry and Disease in the Age of Genomic Medicine, New Therapeutic Approaches to Mendelian Disorders, Genomewide Association Studies and Assessment of the Risk of Disease, Genomic Medicine — An Updated Primer.
Posted by Karen Buckley • April 6th, 2011
Comments are closed.
Get Our Blog Updates Via E-mail!
NEJM in the News
- The Chicago Tribune referenced the 2009 NEJM Original Article, “Racial Differences in Incident Heart Failure among Young Adults.” (May 2)
- CBS News/AP referenced the NEJM Perspective, “Reducing the Risks of Relief — The CDC Opioid-Prescribing Guideline.” (April 29)
- Fox News/Reuters covered the NEJM Review Article, “Workplace Violence against Health Care Workers in the United States.” Business Insider/Reuters also covered the article. (April 28)
- The Guardian covered the NEJM Correspondence, “Visual Acuity after Retinal Gene Therapy for Choroideremia.” (April 28)
- KHN Morning Briefing included the NEJM Perspectives, “Colorectal Cancer on the Decline — Why Screening Can’t Explain It All” and “Moonshot to Malawi,” in a summary of health policy coverage from major news organizations. (April 28)
- ABC News covered the NEJM Review Article, “Workplace Violence against Health Care Workers in the United States.” (April 27)
NEJM on Youtube
- NEJM Group will be exhibiting at the upcoming conferences below:
- European Society of Cardiology in London, England. Aug. 29-Sept. 2. Booth #C-807
- IDWeek in San Diego, CA. Oct. 8-10. Booth #922
- American Society of Nephrology in San Diego, CA. Nov. 5-7. Booth #508
- American Heart Association in Orlando, FL. Nov. 8-10. Booth #822
- American Society of Hematology in Orlando, FL. Dec. 5-7. Booth #514
Tagsabdominal pain anemia asthma breast cancer cancer cardiac arrest Case Records Case Records of the Massachusetts General Hospital chemotherapy Clinical Decisions Clinical Practice Clinical Problem-Solving colorectal cancer COPD CPR Diabetes dyspnea fever global health glucocorticoids HIV hypertension Interactive Medical Cases Massachusetts General Hospital medicine myocardial infarction NEJM nejm 200th anniversary NEJM 200th Anniversary website NEJM Group NEJM Group Open Forum New England Journal of Medicine obesity pregnancy primary care/hospitalist/clinical practice prostate cancer pulmonary embolism septic shock smoking stroke surgery thrombocytopenia tuberculosis type 2 diabetes Venous thromboembolism